Sarepta Refuses FDA Request to Stop Shipping Muscular Dystrophy Drug Elevidys

5 hours ago 1
ARTICLE AD BOX
The regulator had asked Sarepta Therapeutics to halt all shipments of its therapy, Ele­vidys, after three patients died from liver failure after taking it or a similar treatment.
Read Entire Article